Sneha Girap (Editor)

Koen Andries

Updated on
Share on FacebookTweet on TwitterShare on LinkedInShare on Reddit
Covid-19
Name  Koen Andries

Education  Ghent University
Koen Andries httpswwwepoorglearningeventseuropeaninven

Koen andries team drug against multidrug resistant tuberculosis


Koen Andries is a Belgian Janssen Pharmaceutica and professor at the University of Antwerp. In 2005 he and his team published a discovery about a new di-Aryl-Quinoline-based drug (R207910) which promises a shorter and simpler treatment for Tuberculosis (TB).

Contents

Koen Andries EPO Koen Andries Jrme Guillemont Imre Csoka Laurence FF

Koen andries team drug against multidrug resistant tuberculosis


Career

He graduated as a Veterinarian and obtained a PhD at the University of Ghent (Ghent, Belgium) in 1975. He continued his career at the university until 1982, when he started working at Janssen Pharmaceutica in Beerse until 2004. In 2004 he continued his research at Tibotec in Mechelen.

Recognition

  • 2014 winner of the European Inventor Award in the Industry category awarded by the European Patent Office
  • References

    Koen Andries Wikipedia


    Topics
     
    B
    i
    Link
    H2
    L